<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Tumor growth mechanisms &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tumor-growth-mechanisms/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 21 Oct 2025 14:20:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Tumor growth mechanisms &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Innovative Strategy Unveiled for Prostate Cancer Therapy</title>
		<link>https://bioengineer.org/innovative-strategy-unveiled-for-prostate-cancer-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 21 Oct 2025 14:20:31 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Hormone therapy resistance]]></category>
		<category><![CDATA[prostate cancer therapy]]></category>
		<category><![CDATA[Thyroid hormone receptor beta (TRβ)]]></category>
		<category><![CDATA[TRβ inhibitor NH-3]]></category>
		<category><![CDATA[Tumor growth mechanisms]]></category>
		<guid isPermaLink="false">https://bioengineer.org/innovative-strategy-unveiled-for-prostate-cancer-therapy/</guid>

					<description><![CDATA[An international collaboration spearheaded by researchers at the Medical University of Vienna has unveiled a groundbreaking connection between thyroid hormone signaling and the progression of prostate cancer. This novel discovery elucidates the pivotal role of the thyroid hormone receptor beta (TRβ) in driving tumor growth, opening new therapeutic avenues for a disease that remains the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">284415</post-id>	</item>
	</channel>
</rss>
